Market
Italy’s WISE raises $34.8m in Series D to advance spinal cord stimulator development
WISE, an Italian medical device company, raised $34.8 million in Series D funding to advance development of its spinal cord stimulator (SCS) system. The device delivers targeted, directional stimulation via minimally invasive percutaneous implantation. The funding will support continued product development and commercialization efforts.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network